The medical device contract manufacturing industry is continuing to transform through 2024. A decade before COVID highlighted the critical nature of manufacturing infrastructure, there were investors ...
Medical Device Network on MSN
NAMSA acquires Labcorp’s medical device testing assets
The move adds Labcorp’s US biocompatibility, analytical testing, and preclinical research services to Namsa’s operations.
TOLEDO, Ohio, Jan. 8, 2026 /PRNewswire/ -- NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has completed the acquisition of ...
Common mistakes made by medical device companies while developing electromechanical products will lead to significantly more expense and delayed projects. But these mistakes can be avoided, according ...
There has been a rise in pharmaceutical, medical device and digital therapeutics companies investing in telehealth. UpScriptHealth is one telemedicine technology and services organization that caters ...
Headquartered in Northwood, Ohio, Namsa provides medical device testing, clinical research and regulatory consulting to medtech companies This acquisition is Namsa’s 10 th acquisition since becoming ...
Six years after the fall of Theranos, companies are again exploring innovation in blood testing. The medical community is reacting with cautious optimism. Six years after the fall of Theranos, ...
DONGGUAN, GUANGDONG, CHINA, January 13, 2026 /EINPresswire.com/ -- Globally, the medical industry is undergoing a major ...
ProMed, a leading contract manufacturer specializing in medical-grade silicone and plastic components, provides comprehensive support for medical device, pharmaceutical, and combination drug-device ...
NINGBO, ZHEJIANG PROVINCE, CHINA, January 19, 2026 /EINPresswire.com/ -- In recent years, the global healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results